We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

53 hedge funds and large institutions have $104M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

10% more capital invested

Capital invested by funds: $94.6M → $104M (+$9.21M)

8% more funds holding

Funds holding: 49 → 53 (+4)

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
7
Closed
7
Calls
$206K
Puts
–
Net Calls
+$206K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
CCA
Castle Creek Arbitrage
Colorado
+$6.07M
2
PC
Periscope Capital
Ontario, Canada
+$2.61M
3
CCM
Context Capital Management
California
+$2.28M
4
BI
Bulldog Investors
New Jersey
+$542K
5
EC
Elequin Capital
New York
+$506K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$2.88M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.77M
3
BCM
Basso Capital Management
Connecticut
-$1.45M
4
CM
Cohanzick Management
New York
-$517K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$11M – – –
PC
2
Periscope Capital
Ontario, Canada
$7.91M +$2.61M +258,241 +50%
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$7.66M – – –
SCM
4
Shaolin Capital Management
Florida
$7.13M – – –
CCA
5
Castle Creek Arbitrage
Colorado
$6.11M +$6.07M +600,000 New
GL
6
Governors Lane
New York
$5.02M – – –
SC
7
Sculptor Capital
New York
$4.39M – – –
Marshall Wace
8
Marshall Wace
United Kingdom
$4.37M – – –
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$3.85M – – –
WCMNY
10
Westchester Capital Management (New York)
New York
$3.44M – – –
Toronto Dominion Bank
11
Toronto Dominion Bank
Ontario, Canada
$3.08M – – –
CSS
12
Cubist Systematic Strategies
Connecticut
$2.97M -$20 -2 -0%
LA
13
Linden Advisors
New York
$2.56M – – –
TCM
14
Tenor Capital Management
New York
$2.55M – – –
CCM
15
Context Capital Management
California
$2.31M +$2.28M +225,000 New
WAM
16
Wolverine Asset Management
Illinois
$2.27M -$72K -7,115 -3%
WRBC
17
W.R. Berkley Corp
Connecticut
$2.12M – – –
CH
18
CVI Holdings
Delaware
$2.07M – – –
AIMCA
19
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.06M – – –
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$2.06M – – –
Millennium Management
21
Millennium Management
New York
$1.58M – – –
AA
22
AQR Arbitrage
Connecticut
$1.56M – – –
FTCM
23
Fir Tree Capital Management
New York
$1.53M -$5.06K -500 -0.3%
RCM
24
Radcliffe Capital Management
Pennsylvania
$1.33M – – –
MF
25
Magnetar Financial
Illinois
$1.27M – – –
1
2 3

LVAC Hedge Fund Activity: Q4 2022 in Review

53 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q4 2022, worth a combined $104M — up 9.7% from $94.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LVAC positions and 7 closed out — a net gain of 4 holders — while 2 added to existing stakes and 7 trimmed.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $6.07M. The largest seller was UBS O'Connor, exiting entirely with an estimated $2.88M sold.

  • 53 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q4 2022, up from 49 in Q3 2022.
  • Funds reported $104M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q4 2022, up 9.7% quarter-over-quarter.
  • 11 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +4 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $6.07M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $2.88M sold.

Based on aggregated 13F filings for Q4 2022.